An extensive new report
by Research and Markets explores the U.S. market for blood glucose testing and diabetes management. Offered by TriMark Publications, the report notes strong growth in home testing devices for diabetes and POC instruments for healthcare settings. Noninvasive testing is also one of the major new areas for IVD technology in an otherwise mature market for blood glucose testing, the report notes.
According to the report, a significant transition is underway in U.S. glucose testing, driven by new analytical technologies and developments in diabetes treatment. The report covers clinical analytical methods for measuring serum, plasma, or whole-blood glucose concentrations. It also examines clinical measurements devices, reagents, and supplies used in hospitals, clinics, doctors’ offices, and homes. Companies selling, manufacturing, or developing glucose tests for the U.S. market are also analyzed. Among the companies covered are Abbott Laboratories, Beckman Coulter, Cambridge Sensors, GlySure Ltd., Nova Biomedical, and VeraLight.